← Open Payments lookup

ANDREW MERANDE: Open Payments

NPI 1902496425 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$433 in 17 payments from 7 companies in 2025. Trend: 2023 $858 · 2024 $502 · 2025 $433

Food & beverage: $433
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$272
E.R. Squibb & Sons, L.L.C.1$45
Janssen Pharmaceuticals, Inc2$33
Teva Pharmaceuticals USA, Inc.1$23
Neurocrine BioSciences, Inc.1$22
Supernus Pharmaceuticals, Inc.1$20
Vanda Pharmaceuticals Inc.1$19

Products named: REXULTI, COBENFY, INVEGA SUSTENNA, AUSTEDO XR, INGREZZA, Qelbree, FANAPT.

Industry payments across TX — which companies pay providers there.